Anixa Biosciences (ANIX) Other Operating Expenses (2010 - 2023)

Anixa Biosciences' (ANIX) quarterly Other Operating Expenses came in at $161000.0 in Q2 2023, down 58.18% on a QoQ basis from $385000.0 in Q1 2021.

Anixa Biosciences (ANIX) Other Operating Expenses (2010 - 2023) Analysis & Trends

Anixa Biosciences (ANIX) has 12 years of Other Operating Expenses data on file, last reported at $161000.0 in Q2 2023.

Quarterly Other Operating Expenses changed N/A year-over-year to $161000.0 in Q2 2023, while the trailing twelve-month figure through Jan 2024 was $161000.0 (changed N/A YoY) and the FY2023 annual result came in at $161000.0, changed N/A from the prior year.
Other Operating Expenses fell to $161000.0 in Q2 2023, from $385000.0 in the prior quarter.
In the past five years, Other Operating Expenses ranged from a high of $670000.0 in Q1 2019 to a low of $41875.0 in Q3 2019.
A 3-year average of $309950.0 and a median of $291875.0 in 2019 frame the typical range for Other Operating Expenses.
The widest YoY moves for Other Operating Expenses: up 528.06% in 2019, down 87.01% in 2019.
Tracing ANIX's Other Operating Expenses over 3 years: stood at $41875.0 in 2019, then surged by 819.4% to $385000.0 in 2021, then plunged by 58.18% to $161000.0 in 2023.
The last three Other Operating Expenses figures came in at $161000.0 (Q2 2023), $385000.0 (Q1 2021), and $41875.0 (Q3 2019), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Anixa Biosciences	123.62 Mn	123.62 Mn	-

Download Data